EnteroMedics’ CEO Discusses Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Greg Lea Thank you, Mark. For the three months ended March 31, 2014, the Company reported a net loss of 6.7 million, or a $0.10 per share. Research and development expenses were 2.6 million and general … more

View todays social media effects on ETRM

View the latest stocks trending across Twitter. Click to view dashboard

See who EnteroMedics is hiring next, click here to view